Effects of Cyclophosphamide Pulse Therapy on the Clinical and Histopathological Findings, Particularly Crescent Formation, in a Patient with Adult-onset Steroid-refractory Henoch-Schönlein Purpura Nephritis
- PMID: 26328648
- DOI: 10.2169/internalmedicine.54.4330
Effects of Cyclophosphamide Pulse Therapy on the Clinical and Histopathological Findings, Particularly Crescent Formation, in a Patient with Adult-onset Steroid-refractory Henoch-Schönlein Purpura Nephritis
Abstract
A 29-year-old woman was diagnosed with Henoch-Schönlein purpura nephritis (HSPN) based on the presence of purpura and histopathological findings showing crescent formation, mesangial proliferation and IgA deposition in the glomerular mesangium. She was treated with high-dose steroids; however, the nephritic syndrome persisted. Therefore, we diagnosed her with steroid-resistant HSPN and decided to add treatment with cyclosphamide pulse therapy. After one year of treatment, the histopathological findings, including crescent formation and IgA deposition, improved, as confirmed on a renal biopsy, and the patient fulfilled the criteria for complete remission. Cyclophosphamide pulse therapy may be considered an effective treatment for intractable HSPN.
Similar articles
-
Successful treatment of recurrent Henoch-Schönlein purpura nephritis in a renal allograft with tonsillectomy and steroid pulse therapy.Nephrology (Carlton). 2016 Jul;21 Suppl 1:53-6. doi: 10.1111/nep.12770. Nephrology (Carlton). 2016. PMID: 26973131
-
Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.Pediatr Nephrol. 2017 Jul;32(7):1193-1199. doi: 10.1007/s00467-017-3604-9. Epub 2017 Feb 15. Pediatr Nephrol. 2017. PMID: 28204946
-
Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children.World J Pediatr. 2015 Nov;11(4):338-45. doi: 10.1007/s12519-014-0527-4. Epub 2014 Nov 20. World J Pediatr. 2015. PMID: 25410673
-
A case of henoch-schönlein purpura nephritis in pulmonary tuberculosis.Am J Med Sci. 2007 Feb;333(2):117-21. doi: 10.1097/00000441-200702000-00010. Am J Med Sci. 2007. PMID: 17301592 Review.
-
Henoch-Schönlein purpura nephritis in children: incidence, pathogenesis and management.World J Pediatr. 2015 Feb;11(1):29-34. doi: 10.1007/s12519-014-0534-5. Epub 2014 Dec 29. World J Pediatr. 2015. PMID: 25557596 Review.
Cited by
-
Refractory Cutaneous IgA Vasculitis Treated with Omega-3 Fatty Acids.Case Rep Dermatol. 2016 Nov 29;8(3):333-340. doi: 10.1159/000452320. eCollection 2016 Sep-Dec. Case Rep Dermatol. 2016. PMID: 28461812 Free PMC article.
-
Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.Clin Exp Nephrol. 2020 Jan;24(1):73-81. doi: 10.1007/s10157-019-01795-6. Epub 2019 Oct 11. Clin Exp Nephrol. 2020. PMID: 31605314
-
Involvement of activated cytotoxic T lymphocytes and natural killer cells in Henoch-Schönlein purpura nephritis.Clin Transl Immunology. 2020 Nov 24;9(11):e1212. doi: 10.1002/cti2.1212. eCollection 2020. Clin Transl Immunology. 2020. PMID: 33282293 Free PMC article.
-
The response of the Oxford classification to steroid in IgA nephropathy: a systematic review and meta-analysis.Oncotarget. 2017 Jul 26;8(35):59748-59756. doi: 10.18632/oncotarget.19574. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous